NCT07039877View on ClinicalTrials.gov

Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 2, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

April 30, 2026

Conditions
Acute Lymphobkastic LeukemiaAcute Lymphoblastic Leukaemia RecurrentPhiladelphia Chromosome Negative ALL
Interventions
DRUG

Venetoclax low dose with itraconazole

The investigators will add venetoclax in low dose (100 mg) with itraconazole to the pediatric inspired regimen TACL to enchance the complete response rate

Trial Locations (1)

64360

RECRUITING

Hospital Universitario Dr. Jose E. Gonzalez, Monterrey

All Listed Sponsors
lead

Hospital Universitario Dr. Jose E. Gonzalez

OTHER